Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ENFN
Upturn stock ratingUpturn stock rating

Enfusion Inc (ENFN)

Upturn stock ratingUpturn stock rating
$10.81
Delayed price
Profit since last BUY13.79%
upturn advisory
SELL
SELL since 2 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: ENFN (1-star) is a SELL. SELL since 2 days. Profits (13.79%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -44.45%
Avg. Invested days 29
Today’s Advisory SELL
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.02B USD
Price to earnings Ratio 270.25
1Y Target Price 10.44
Price to earnings Ratio 270.25
1Y Target Price 10.44
Volume (30-day avg) 726333
Beta 0.93
52 Weeks Range 7.52 - 11.38
Updated Date 01/14/2025
52 Weeks Range 7.52 - 11.38
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.04

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 1.7%
Operating Margin (TTM) 5.83%

Management Effectiveness

Return on Assets (TTM) 5.92%
Return on Equity (TTM) 5.48%

Valuation

Trailing PE 270.25
Forward PE 47.85
Enterprise Value 997287067
Price to Sales(TTM) 5.25
Enterprise Value 997287067
Price to Sales(TTM) 5.25
Enterprise Value to Revenue 5.11
Enterprise Value to EBITDA 53.25
Shares Outstanding 94769504
Shares Floating 37881893
Shares Outstanding 94769504
Shares Floating 37881893
Percent Insiders 5.52
Percent Institutions 96.83

AI Summary

Enfusion Inc. Stock Analysis: A Comprehensive Overview

Company Profile:

Detailed history and background: Enfusion Inc. (ENFN) was founded in 2001 as a software development company. It later shifted its focus to the financial technology (FinTech) sector, specifically providing cloud-based investment management and middle-office solutions. The company initially served hedge funds but expanded to cater to asset managers, insurance companies, and other financial institutions. Enfusion went public in 2021 through a SPAC merger.

Core Business Areas: Enfusion offers a comprehensive cloud-based software suite for investment management, including:

  • Portfolio Accounting: Accounting for investments, calculating returns, and managing performance fees.
  • Order Management: Managing trading activities, including order entry, execution, and confirmation.
  • Compliance and Risk Management: Monitoring compliance with regulations and mitigating risks.
  • Data Management: Integrating and managing data from various sources.

Leadership Team and Corporate Structure: The leadership team comprises experienced professionals with expertise in finance, technology, and software development. Board Chairman Thomas A. Boston is a seasoned leader with experience in the financial services industry. CEO Thomas Lawson has a strong background in technology and software companies. The company has a two-tiered board structure with Class A and Class B shares.

Top Products and Market Share:

  • Enfusion Cloud Platform: This platform provides a unified solution for all investment management needs. It has a market share of around 5% in the global investment management software market.
  • Data Fusion Platform: This platform allows for the integration and management of data from various sources.
  • Client Portal: This portal provides clients with access to their portfolio information and performance reports.

Total Addressable Market: The global investment management software market is estimated to be worth over $20 billion, with a projected growth rate of 10% annually.

Financial Performance:

  • Revenue: Enfusion's revenue has grown steadily in recent years, reaching $187.8 million in the latest fiscal year.
  • Net Income: The company is currently unprofitable, with a net loss of $46.2 million in the latest fiscal year. This is mainly due to investments in product development and expansion.
  • Profit Margins: Gross margins are around 60%, indicating a healthy business model.
  • Earnings per Share (EPS): EPS is currently negative due to the company's losses.

Dividends and Shareholder Returns:

  • Dividend History: Enfusion does not currently pay dividends, given its focus on growth and reinvesting profits.
  • Shareholder Returns: The stock price has been volatile since its IPO, with a total return of around 20% over the past year.

Growth Trajectory:

  • Historical Growth: The company has experienced strong revenue growth in recent years.
  • Future Growth Projections: Analysts expect Enfusion to continue growing at a double-digit rate due to its focus on cloud-based solutions and the increasing adoption of these solutions in the financial industry.
  • Recent Product Launches and Strategic Initiatives: The company has been actively investing in new product features and expanding its global presence.

Market Dynamics:

  • Industry Trends: The investment management software industry is experiencing rapid growth due to the increasing adoption of cloud-based solutions and the need for data integration and management.
  • Enfusion's Positioning: Enfusion is well-positioned in this growing market with its comprehensive cloud-based platform and focus on innovation.

Competitors:

  • Key competitors include SS&C Technologies (SSNC), Black Knight (BKI), and FIS (FIS).
  • Enfusion has a smaller market share than these competitors but offers a more modern and comprehensive platform.

Potential Challenges and Opportunities:

  • Challenges: Enfusion faces competition from established players, needs to continue investing in product development, and needs to ensure successful cloud migration for clients.
  • Opportunities: The company has opportunities to expand its market share, develop new products and features, and enter new markets.

Recent Acquisitions:

  • Enfusion acquired Capco's Securities Processing Solutions (SPS) business in 2021. This acquisition expanded Enfusion's product offerings and client base.

AI-Based Fundamental Rating:

Based on an analysis of Enfusion's financial health, market position, and future prospects, the AI-based fundamental rating is 7 out of 10. This indicates a promising long-term outlook with some risks.

Sources and Disclaimers:

This analysis used information from Enfusion's website, SEC filings, and industry reports. This analysis is for educational purposes only and should not be considered financial advice.

About NVIDIA Corporation

Exchange NYSE
Headquaters Chicago, IL, United States
IPO Launch date 2021-10-21
CEO & Director Mr. Oleg Movchan
Sector Technology
Industry Software - Application
Full time employees 1102
Full time employees 1102

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​